[Flow cytometric detection of the rate of intracellular anthracycline-accumulation]. 1994

H Isobe, and T Ishida, and K Yamazaki, and H Makino, and M Kamachi, and T Hanada, and S Ogura, and N Shinohara, and Y Kawakami
First Dept. of Medicine, School of Medicine, Hokkaido University.

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D001749 Urinary Bladder Neoplasms Tumors or cancer of the URINARY BLADDER. Bladder Cancer,Bladder Neoplasms,Cancer of Bladder,Bladder Tumors,Cancer of the Bladder,Malignant Tumor of Urinary Bladder,Neoplasms, Bladder,Urinary Bladder Cancer,Bladder Cancers,Bladder Neoplasm,Bladder Tumor,Cancer, Bladder,Cancer, Urinary Bladder,Neoplasm, Bladder,Neoplasm, Urinary Bladder,Tumor, Bladder,Tumors, Bladder,Urinary Bladder Neoplasm
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas
D000903 Antibiotics, Antineoplastic Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. Antineoplastic Antibiotics,Cytotoxic Antibiotics,Antibiotics, Cytotoxic
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured

Related Publications

H Isobe, and T Ishida, and K Yamazaki, and H Makino, and M Kamachi, and T Hanada, and S Ogura, and N Shinohara, and Y Kawakami
April 1986, Cancer research,
H Isobe, and T Ishida, and K Yamazaki, and H Makino, and M Kamachi, and T Hanada, and S Ogura, and N Shinohara, and Y Kawakami
April 1996, Cytometry,
H Isobe, and T Ishida, and K Yamazaki, and H Makino, and M Kamachi, and T Hanada, and S Ogura, and N Shinohara, and Y Kawakami
June 1994, Anti-cancer drugs,
H Isobe, and T Ishida, and K Yamazaki, and H Makino, and M Kamachi, and T Hanada, and S Ogura, and N Shinohara, and Y Kawakami
January 2007, Methods in molecular medicine,
H Isobe, and T Ishida, and K Yamazaki, and H Makino, and M Kamachi, and T Hanada, and S Ogura, and N Shinohara, and Y Kawakami
January 1994, Cancer chemotherapy and pharmacology,
H Isobe, and T Ishida, and K Yamazaki, and H Makino, and M Kamachi, and T Hanada, and S Ogura, and N Shinohara, and Y Kawakami
July 1990, Bone marrow transplantation,
H Isobe, and T Ishida, and K Yamazaki, and H Makino, and M Kamachi, and T Hanada, and S Ogura, and N Shinohara, and Y Kawakami
January 1986, Annals of the New York Academy of Sciences,
H Isobe, and T Ishida, and K Yamazaki, and H Makino, and M Kamachi, and T Hanada, and S Ogura, and N Shinohara, and Y Kawakami
May 2001, Current protocols in cytometry,
H Isobe, and T Ishida, and K Yamazaki, and H Makino, and M Kamachi, and T Hanada, and S Ogura, and N Shinohara, and Y Kawakami
September 2000, Journal of immunological methods,
H Isobe, and T Ishida, and K Yamazaki, and H Makino, and M Kamachi, and T Hanada, and S Ogura, and N Shinohara, and Y Kawakami
January 1986, Cytometry,
Copied contents to your clipboard!